The goal of this proposal is to determine the tumor suppressor role of the wild type K-ras gene in chemical carcinogenesis. Although the ras genes have long been established as proto-oncogenes, their dominant role in cell transformation has been questioned in previous studies. Recently, a lung tumor bioassay in heterozygous K-ras deficient mice was conducted by us to evaluate the effect of presence of the wild type K-ras allele on mouse lung tumorigenesis. Mice with a heterozygous K-ras deficiency had a significantly increased susceptibility to the chemical induction of lung tumors when compared to wild type mice, suggesting that a single copy of a wild-type K-ras allele could suppress chemically induced lung carcinogenesis. In addition, wild type K-ras allele inhibited colony formation and tumor development of a transformed cell line that contained a mutant K-ras. Moreover, published data suggest that the wild type K-ras allele is deleted in mouse lung adenocarcinomas carrying a mutant K-ras. In this proposal, we hypothesize that the wild type K-ras allele has tumor suppressor activity and is lost during tumor progression. Accordingly, four specific aims are proposed to test our hypothesis: 1) to examine the effect of the wild type K-ras allele on tumorigenesis and growth characteristics of lung tumor cell lines; 2) to evaluate the correlation between the presence of a mutant K-ras allele and the loss of wild type K-ras allele in human lung tumors; 3) to determine the role of the wild type K-ras allele at various stages of mouse lung carcinogenesis; and 4) to determine the effect of K-ras heterozygous deficiency on mouse lymphomagenesis and colon carcinogenesis. We believe that we have uncovered a novel tumor suppressor function of a gene identified and characterized as a classical oncogene. The K-ras gene seems to have dual function. On one hand it promotes cancer development as a gain-of-function oncogene and on other hand, it inhibits cancer as a loss of function tumor suppressor gene. Understanding the newly discovered role of the wild type K-ras has immediate and important implications for the development of various ras-directed gene therapy and drug development. Thus, this proposal offers a unique opportunity to characterize the tumor suppressor role of the wild type K-ras gene in carcinogenesis.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Liu, Pengyuan; Yang, Ping; Wu, Xifeng et al. (2010) A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res 70:3128-35
You, Ming; Wang, Daolong; Liu, Pengyuan et al. (2009) Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res 15:2666-74
Liu, Pengyuan; Vikis, Haris G; Wang, Daolong et al. (2008) Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 100:1326-30
Vikis, Haris; Sato, Mitsuo; James, Michael et al. (2007) EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 67:4665-70
Lu, Yan; Lemon, William; Liu, Peng-Yuan et al. (2006) A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 3:e467
Tommasi, Stella; Dammann, Reinhard; Zhang, Zhongqiu et al. (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65:92-8